Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fudosteine for chronic sinusitis
ChiCTR1900022466Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fudosteine in rhinosinusitis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Nasal secretion traits before and after treatment, VAS score and 3 more. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
fudosteine
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on ChiCTR1900022466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022466.